Rebalix
Amundi · sheet of 10 September 2026
Amundi · sheet of 10 September 2026ETF sheet · official issuer and register data
Amundi Global Corporate Bond 1-5Y Highest Rated ESG UCITS ETF GBP Hedged Dist
GCBH · LU2780871237 · class UCITS ETF GBP Hedged Dist · GBP · domicile Luxembourg
Bonds · Corporate GBP · 1-5 years · GlobalGBP-hedged share classSFDR art. 8
Index tracked: Bloomberg MSCI ESG Global Corporate A+ 1-5 Year Select Index GBP Hedged
- TER
- 0.18%+ trans. 0.01%
- Fund size
- 2 m EUR
- Tracking difference
- —not computable
- 🇮🇹 tax rate
- 26.00%white list 0.00%
- Replication
- Physical
- Income
- Distributingannual
- Duration
- 2.49 yrsshort (≤3 years)
Launch 16 Jun 2025 · costs from the KID as of 2 Sept 2026 · 1,997 securities held
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 4 Aug 2026
This Sub-Fund is passively managed. The objective of this Sub-Fund is to track the performance of Bloomberg MSCI ESG Global Corporate A+ 1-5 Year Select Index (the "Index") and to minimize the tracking error between the net asset value of the Sub-Fund and the performance of the Index. The anticipated level of tracking error under normal market conditions is indicated in the Sub-Fund’s prospectus. The Index is a Total Return Index: the coupons paid by the index constituents are included in the index return. The Sub-Fund promotes environmental and/or…
Performance since series start (in euro) — base 100
20 Jun 2025 → 8 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
Returns in euro
| 1 year | +3.4% |
| 3 years | series too young |
| 5 years | series too young |
| 10 years | series too young |
| Since series start | +3.3% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 1.70% | 1.70% | — |
| Max drawdown | −1.34% | −1.34% | — |
| Sharpe | -0.63 | -0.63 | — |
| Sortino | -0.76 | -0.76 | — |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · GCBH · LU27808712371
RebalixGCBH · LU2780871237 · sheet of 10 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years
Not honestly computable: hedged class: the issuer’s published index is unhedged — the gap would measure the exchange rate, not replication. We don’t show it
Fixed income — as declared by the issuer
Factsheet · 31 Jul 2026 · investment-grade share (BBB−/Baa3 and above): 99.4%
Rating breakdown (% of fund)
Maturity breakdown (% of fund)
Distributions · per share, in GBP
Frequency: annual · last 12 months: 0.19 GBP (0.92% of NAV) · 9 months of history: not a full year · last ex-date 9 Dec 2025
| Year | Payments | Total (GBP) |
|---|---|---|
| 2025 | 1 | 0.19 |
Holdings
Portfolio as declared by the issuer · 1 Sept 2026 · 1,997 securities · top-10 weight = 2.3%
Countries (% of fund)
Sectors (% of fund)
Listing venues
ESMA register (FIRDS) and official exchange lists
No EU listing in the ESMA register.
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/LU2780871237
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/LU2780871237
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · GCBH · LU27808712372